Accipiter Biosciences
Biotechnology
Designs proteins that can act on multiple biological targets for drug development.
Source- Reported stage
- Seed
- Local presence
- Seattle
$10.5M seed top-up reported July 31, 2026, following $12.7M at launch.
Research snapshot: 2026-11-01. Funding may have changed since the linked report.